Coronary CT angiography is a useful tool in detecting prevalence and type of coronary artery fistulas.
Coronary CT angiography (CTA) is a useful, noninvasive imaging modality for the detection of coronary artery fistula (CAF), according to an article published in the American Journal of Roentgenology.
Researchers from South Korea undertook a retrospective study to determine if the prevalence and type of CAF could be determined through coronary CTA.
The study comprised 6,341 patients (3,461 men and 2,880 women). The patients had a mean age of 59. All had undergone ECG-gated coronary CTA at the researchers’ institution between March 2009 and November 2011. The researchers evaluated the prevalence of CAF and they analyzed the morphologic features, including vessel of origin, drainage site, size and presence of an aneurysmal sac. Cardiac and pulmonary findings were included in the analysis.
The results showed that of the 6,341 patients, 56 (0.9 percent) had CAF.
The findings also showed that lung parenchymal or vascular anomaly was more frequently found in coronary to bronchial artery fistulas, combined coronary to pulmonary and coronary to bronchial artery fistulas, and coronary artery to superior vena cava fistulas than in coronary to pulmonary artery and coronary artery to cardiac chamber fistulas.
“The prevalence of CAF at coronary CTA was 0.9 percent, which is higher than the known prevalence based on conventional angiographic findings (0.05–0.25 percent),” the authors wrote. “Coronary CTA is a useful, noninvasive imaging modality for the detection of CAF.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.